Signal active
Contact Information
Social
Primary Organization
2003
11-50
Biotechnology, Health Care, Pharmaceutical
Bio
Thorsteinn Loftsson co-founded Oculis in 2003 and has since then been on the Company’s Board of Directors.
Dr. Loftsson is a leading scientist in the field of cyclodextrin based drug delivery. He has served as an advisor to many of the global pharmaceutical companies on drug formulations and IP rights. He co-founded and served as CEO of the biotechnology company Cyclops ehf. from 1994 until it was acquired by DeCode Genetics in 2000. At that time, Dr. Loftsson took on the role of a scientific advisor at Decode Genetics (until 2004).
Dr. Loftsson received an MS degree in Pharmacy from the University of Copenhagen, School of Pharmaceutical Sciences and a MS and Ph.D. degrees in Pharmaceutical Chemistry from the University of Kansas, Department of Pharmaceutical Chemistry. He has served as Assistant, Associated and full Professor on the Faculty of Pharmaceutical Sciences, University of Iceland for the past 36 years. In 1980 to 1996, he served as an Adjunct Associate Professor and later Adjunct Professor at the College of Pharmacy, University of Florida.
Dr. Loftsson has authored and co-authored over 220 peer-reviewed papers in addition to couple of books and number of book chapters. He is a fellow of the AAPS and is on the editorial boards of Journal of Pharmaceutical Sciences, International Journal of Pharmaceuticals, Journal of drug Delivery Science and Technology, Die Pharmazie and Journal of Pharmacy and Pharmacology. In 2014, he was recognised as one of the World's Most Influential Scientific Minds by Thomson Reuters.
Location
N/A
Jobs history
1
Oculis
Board Member
2003 - Current
Educations
1
University of Kansas School of Law
Pharmaceutical Chemistry
Profile Resume
Thorsteinn Loftsson is the Chief Scientific Officer at Oculis, based in Europe. With a background in Biotechnology, Thorsteinn Loftsson has a rich history of leadership and innovation.Thorsteinn Loftsson studied M.S. and Ph.D. Pharmaceutical Chemistry at University of Kansas School of Law. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.